Tax Credits: Concentrix

Debate between Stephen McPartland and Jane Ellison

Wednesday 14th September 2016 Commons Chamber

[Jane Ellison]

I am not able to respond immediately from the Dispatch Box to one or two of the points raised by the hon. Gentleman. My clear priority and that of HMRC at the moment is to make sure that we resolve the outstanding cases, and in particular the difficult cases for vulnerable constituents. We will then turn our mind to some of the other points that he made. We are not renewing the contract, but we intend to continue to bear down on error and fraud. That is important, as there is a lot in the system, but we have had a great deal of success in recent years in reducing it—the amount of fraud in the system has halved from £800 million to £400 million. We need to continue to bear down on that, because money that is fraudulently obtained is money that is not available to taxpayers. It remains vital that we address that matter. But for the moment, my primary consideration is resolving the difficult cases to make sure that we look after our most vulnerable citizens.

[Stephen McPartland (Stevenage) (Con)]

I am a big fan of supporting those people who are trying very hard to get on in life and who depend on tax credits. One of my concerns is that over the next eight months those people will still be dealt with by Concentrix and will still have that fear of being falsely accused and prosecuted, almost, as they go forward. What reassurance can the Minister give that those people will be looked after, and will HMRC carry on with the contract in the future or will it issue it for new tender?

[Jane Ellison]

I have laid out the arrangements we are putting in place. The contract ends next spring. In the meantime, HMRC will support Concentrix on the outstanding cases—in particular, looking at more complex cases and supporting back-office functions while Concentrix staff focus on resolving already open cases. It is important to have a bit of perspective. Concentrix has assisted the Government and, indeed, the taxpayer in correctly identifying a lot of claims as either erroneous or fraudulent. It is important to keep the matter in perspective, but HMRC has made clear its operational intention not to continue the contract beyond the spring.

Radiotherapy Services (North East Hertfordshire)

Debate between Stephen McPartland and Jane Ellison

Wednesday 4th February 2015 Westminster Hall

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

I congratulate my hon. and learned Friend the Member for North East Hertfordshire (Sir Oliver Heald) on securing this debate on, as he pointed out, a very apt day: world cancer day. I am still getting used to the idea of the MPs’ road trip that he appears to be planning for himself, my right hon. Friend the Member for North East Bedfordshire (Alistair Burt) and my hon. Friend the Member for Stevenage (Stephen McPartland). I will come on to address the issue of access, but that certainly sounds like an offer that no one could refuse.

[Stephen McPartland]

NHS England has refused us on several occasions. We keep pushing, so we would be grateful if the Minister could persuade it to accept the offer to embark on our road trip.

[Jane Ellison]

I will certainly draw NHS England’s attention to the force with which the invitation was put in this debate.

Let me say a few words about the bigger picture on cancer before we go into the detail in the contribution by my hon. and learned Friend the Member for North East Hertfordshire. The Government are committed to improving cancer outcomes and matching the best in Europe. As Members are aware, we do not match the best in Europe; we were certainly lagging behind some important countries when the Government came to office in 2010.

The 2011 strategy, which was backed by £750 million, set the ambition of saving an additional 5,000 lives a year. We believe that we are on track to save an additional 12,000 lives a year, far exceeding that ambition. Much of the focus has been on early diagnosis and awareness. Given the clear interest in cancer that Members have expressed by being here, I hope that they will join me in welcoming the announcement of NHS England’s cancer taskforce, which is charged with designing a new cancer strategy for the NHS to take us through to 2020.

I thought Members might be interested in the statistics for East and North Hertfordshire NHS Trust over the last 12 months. Some 2,881 more patients with suspected cancers were seen than in 2010—a 49% increase. In addition, 239 more patients were treated for cancer than in 2009-10—an 11% increase. Local NHS staff, to whom I pay tribute, are therefore doing a good job of seeing more people.

--- Later in debate ---

[Jane Ellison]

I completely understand that point. I expect local clinical leadership to understand the expertise and staffing available. All those factors will be taken in the round and looked at, because the work is specialist. I would expect the NHS to look at things such as his suggestion about the new machines at Mount Vernon. I will of course write, drawing attention to the particular concerns of my hon. and learned Friend and of my hon. Friend the Member for Stevenage about access and the travel distances. They, however, would in turn expect the local NHS to look at issues such as the distribution of expertise to ensure that the continuity of expertise was available.

[Stephen McPartland]

I am grateful to the Minister, who is being generous in giving way. The local Lister hospital in Stevenage is part of the same trust as Mount Vernon. The chief executive and the cancer surgeons of the local hospital support the concept of a satellite radiotherapy unit, so the local NHS supports having such a unit in Stevenage, or nearby in Hertfordshire. The issue we have is with NHS England getting on and commissioning it. The problem is that we cannot understand how the NHS is getting travel times of 45 minutes.

[Jane Ellison]

I have certainly picked up from the debate the importance of the issue of travel times. I will make a particular point of drawing that to NHS England’s attention.

It is always heartening to hear that colleagues are so engaged with their local health leaders as to be working together on such things. I am sure that that will all be fed into the process of making a decision. That will have to look at the implications for the whole cancer pathway, and all the other patients who receive services as part of the cancer network.

My hon. and learned Friend the Member for North East Hertfordshire, my right hon. Friend the Member for North East Bedfordshire and my hon. Friend the Member for Stevenage are hoping to meet the local NHS, as they detailed. Again, it sounds as if all the right people will be at that meeting. I strongly encourage colleagues to continue such meetings. Such a high level of engagement with local clinical leaders can only be to the benefit of their constituents. They will want to get the best and safest services for their constituents.

I congratulate my hon. and learned Friend the Member for North East Hertfordshire, who was supported by other right hon. and hon. Friends, on the debate and on their interest in the issue, which they are championing on behalf of their constituents. It is great to hear that they have the local newspaper, The Comet, involved, because it is always good for local newspapers to be involved in health campaigns, drawing attention to and explaining the issues to their readership. It sounds like a real commitment to fighting cancer in their part of the country. I commend them. I will draw the debate to the attention of those who will be interested, including NHS England. I am happy to continue to liaise with Members, and to hear how they get on with their discussions and the eventual outcome of the local review.

Question put and agreed to.